68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Neuroendocrine cancer is an unusual disease and often goes undetected by routine imaging. The
68Ga-DOTATATE PET Scan is a novel scanning method that may have improved sensitivity and
resolution specifically for neuroendocrine tumors. Patients with neuroendocrine tumors will
be imaged with this agent and it will be compared to conventional imaging methods to
determine the safety and efficacy of this radiopharmaceutical.